La primera noticia sobre el ébola del año a sido el 22 de marzo
http://www.voanews.com/content/deadly-ebola-virus-confirmed-in-guinea/1877059.html
En enero de 2014 la única empresa que investiga la cura del ébola lanzó el primer ensayo con personas.
http://investor.tekmirapharm.com/releasedetail.cfm?ReleaseID=819313
Además, ésta empresa, Tekmira, colabora con el departamento de defensa de los EEUU.
"on March 5, Canadian firm Tekmira Pharmaceuticals Corp. unveiled a project with the U.S. Food and Drug Administration, which agreed to a fast-track grant to develop TKM-Ebola, an anti-Ebola viral therapeutic, according to a company press release. It would augment what the Canadian company had already put into the project as part of a $140 million contract with the U.S. Department of Defense starting in 2010. "
http://www.ibtimes.com/ebola-economics-vacations-vaccines-very-expensive-monkeys-1563617
Evolución en bolsa de Tekmira
http://finance.yahoo.com/q/bc?s=TKMR+Basic+Chart&t=3m
No hay comentarios:
Publicar un comentario